You have no items in your shopping cart.
Below see the list of available generics of Lapatinib 250 mg Tablet. Upload prescription & buy Lapatinib online at the best price from the world's most trusted international pharmacy - Drugssquare.com. We are a certified supplier & exporter of FDA-approved generic versions of Lapatinib in USA, UK, China, Hong Kong, Nigeria, Australia, UAE, Philippines, Peru, Brazil, Malaysia, Venezuela, Vietnam, Ukraine, and other countries. From India, we ship our generics at the very best price you'd never get from any other online medical store. More than 30,000 international patients have used our service to receive their prescription and over-the-counter medications.
Are you a new user? Do not worry! Create an account today and get the best deals, coupons, and discounts on every purchase. And if you have any questions or if you would like to inquire about any other Indian brand of Lapatinib that is not listed below, please fill out our contact form.
Uses of Lapatinib 250 mg - Lapatinib is used in combination with other drugs to treat a certain type of breast cancer that has spread to other parts of the body and that has not responded to other cancer treatments.
Dosage of Lapatinib 250 mg - The recommended dose of lapatinib in combination with capecitabine is 1,250 mg once daily continuously. In combination with an aromatase inhibitor (letrozole), the recommended dose is 1,500 mg once daily continuously. All tablets should be taken together at the same time, at least 1 hour before or 1 hour after a meal.
Is Lapatinib Tablet Safe to Use During Pregnancy or While Breastfeeding? - This breast cancer drug should be used during pregnancy only if the expected benefit justifies the potential risk to the fetus. It is not known whether lapatinib is excreted in human milk. Breast-feeding must be discontinued in women who are receiving treatment with Lapatinib and for at least 5 days after the last dose.
Drug Interactions of Lapatinib 250mg - This medicine can interact with many medicines; therefore, advise patients to report to their healthcare provider the use of any other prescription or non-prescription drugs or herbal products.